{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:42:55Z","timestamp":1786981375651,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11504-7","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:41:27Z","timestamp":1773315687000},"page":"2865-2888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Repurposing DrugBank compounds as NAD-dependent deacetylase sirtuin 2 inhibitors via QSAR modelling with gradient boosting algorithms and all-atom molecular simulations"],"prefix":"10.1007","volume":"30","author":[{"given":"Yassir","family":"Boulaamane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmae","family":"Saih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelkrim","family":"Guendouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Maurady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"11504_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.14.2.223","author":"J Parkinson","year":"2002","unstructured":"Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. https:\/\/doi.org\/10.1176\/jnp.14.2.223","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"11504_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T (2016) The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology 46(4):292\u2013300. https:\/\/doi.org\/10.1159\/000445751","journal-title":"Neuroepidemiology"},{"issue":"10","key":"11504_CR3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/14737175.2020.1800454","volume":"20","author":"D Colombo","year":"2020","unstructured":"Colombo D, Pnevmatikou P, Melloni E, Keywood C (2020) Therapeutic innovation in Parkinson\u2019s disease: a 2020 update on disease-modifying approaches. Expert Rev Neurother 20(10):1047\u20131064. https:\/\/doi.org\/10.1080\/14737175.2020.1800454","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"11504_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H et al (2002) \u0391-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"issue":"3","key":"11504_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/IJMS10030724","volume":"10","author":"K Beyer","year":"2009","unstructured":"Beyer K, Domingo-S\u00e0bat M, Ariza A (2009) Molecular pathology of Lewy Body diseases. Int J Mol Sci 10(3):724. https:\/\/doi.org\/10.3390\/IJMS10030724","journal-title":"Int J Mol Sci"},{"key":"11504_CR6","unstructured":"F. R. Cabrero and E. H. Morrison, \u201cLewy Bodies,\u201d StatPearls, July 2023, Accessed 15 Mar 2024. [Online]. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536956\/"},{"key":"11504_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2021.666585","author":"N Bisi","year":"2021","unstructured":"Bisi N et al (2021) \u03b1-Synuclein: an all-inclusive trip around its structure, influencing factors and applied techniques. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2021.666585","journal-title":"Front Chem"},{"key":"11504_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2020.00072","volume":"12","author":"SM Hernandez","year":"2020","unstructured":"Hernandez SM, Tikhonova EB, Karamyshev AL (2020) Protein-protein interactions in Alpha-Synuclein biogenesis: new potential targets in Parkinson\u2019s disease. Front Aging Neurosci 12:8. https:\/\/doi.org\/10.3389\/fnagi.2020.00072","journal-title":"Front Aging Neurosci"},{"key":"11504_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of Sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"key":"11504_CR10","doi-asserted-by":"publisher","unstructured":"\u201cThe mechanism of sirtuin 2\u2013mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease | PLOS Biology\u201d. Accessed 12 July 2025. [Online]. Available: https:\/\/doi.org\/10.1371\/journal.pbio.2000374","DOI":"10.1371\/journal.pbio.2000374"},{"issue":"Volume 5","key":"11504_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol Mech Dis 5(Volume 5):253\u2013295. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092250","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"8","key":"11504_CR12","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbapap.2009.09.009","volume":"1804","author":"BD Sanders","year":"2010","unstructured":"Sanders BD, Jackson B, Marmorstein R (2010) Structural basis for sirtuin function: what we know and what we don\u2019t. Biochim Biophys Acta 1804(8):1604\u20131616. https:\/\/doi.org\/10.1016\/j.bbapap.2009.09.009","journal-title":"Biochim Biophys Acta"},{"key":"11504_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT (2018) Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett 666:48\u201357. https:\/\/doi.org\/10.1016\/j.neulet.2017.12.037","journal-title":"Neurosci Lett"},{"issue":"4","key":"11504_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41582-019-0155-7","volume":"15","author":"A Elkouzi","year":"2019","unstructured":"Elkouzi A, Vedam-Mai V, Eisinger RS, Okun MS (2019) Emerging therapies in Parkinson disease\u2014repurposed drugs and new approaches. Nat Rev Neurol 15(4):204\u2013223. https:\/\/doi.org\/10.1038\/s41582-019-0155-7","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"11504_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"11504_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2260879","author":"Y Boulaamane","year":"2023","unstructured":"Boulaamane Y et al (2023) Exploring natural products as multi-target-directed drugs for Parkinson\u2019s disease: an in-silico approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2260879","journal-title":"J Biomol Struct Dyn"},{"key":"11504_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/S11030-023-10691-X\/METRICS","author":"Y Boulaamane","year":"2023","unstructured":"Boulaamane Y, Jangid K, Britel MR, Maurady A (2023) Probing the molecular mechanisms of \u03b1-synuclein inhibitors unveils promising natural candidates through machine-learning QSAR, pharmacophore modeling, and molecular dynamics simulations. Mol Divers. https:\/\/doi.org\/10.1007\/S11030-023-10691-X\/METRICS","journal-title":"Mol Divers"},{"key":"11504_CR18","doi-asserted-by":"publisher","first-page":"110199","DOI":"10.1016\/j.compbiomed.2025.110199","volume":"191","author":"Y Boulaamane","year":"2025","unstructured":"Boulaamane Y et al (2025) Computational screening of natural products as tryptophan 2,3-dioxygenase inhibitors: insights from CNN-based QSAR, molecular docking, ADMET, and molecular dynamics simulations. Comput Biol Med 191:110199. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110199","journal-title":"Comput Biol Med"},{"key":"11504_CR19","unstructured":"Landrum G (2013) RDKit: a software suite for cheminformatics, computational chemistry, and predictive modelling. Greg Landrum 8"},{"issue":"9","key":"11504_CR20","first-page":"1","volume":"14","author":"W McKinney","year":"2011","unstructured":"McKinney W (2011) Pandas: a foundational Python library for data analysis and statistics. Python High Perform Sci Comput 14(9):1\u20139","journal-title":"Python High Perform Sci Comput"},{"issue":"1","key":"11504_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13321-023-00743-7","volume":"15","author":"D Boldini","year":"2023","unstructured":"Boldini D, Grisoni F, Kuhn D, Friedrich L, Sieber SA (2023) Practical guidelines for the use of gradient boosting for molecular property prediction. J Cheminform 15(1):73. https:\/\/doi.org\/10.1186\/s13321-023-00743-7","journal-title":"J Cheminform"},{"key":"11504_CR22","unstructured":"Chen T et al. (2015) Xgboost: extreme gradient boosting"},{"key":"11504_CR23","doi-asserted-by":"publisher","unstructured":"Akiba T, Sano S, Yanase T, Ohta T, Koyama M (2019) Optuna: a next-generation hyperparameter optimization framework. In: Proceedings of the 25th ACM SIGKDD international conference on knowledge discovery & data mining. KDD \u201919. Association for Computing Machinery, New York, pp 2623\u20132631. https:\/\/doi.org\/10.1145\/3292500.3330701","DOI":"10.1145\/3292500.3330701"},{"issue":"10","key":"11504_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-3-33\/TABLES\/2","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3(10):1\u201314. https:\/\/doi.org\/10.1186\/1758-2946-3-33\/TABLES\/2","journal-title":"J Cheminform"},{"issue":"5\u20136","key":"11504_CR25","first-page":"5","volume":"17","author":"TA Halgren","year":"1996","unstructured":"Halgren TA (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17(5\u20136):5\u20136. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","journal-title":"J Comput Chem"},{"key":"11504_CR26","doi-asserted-by":"publisher","unstructured":"\u201cOpenMMDL\u2014Simplifying the complex: building, simulating, and analyzing protein\u2013ligand systems in OpenMM. J Chem Inf Model. [Online]. Available: https:\/\/doi.org\/10.1021\/acs.jcim.4c02158. Accessed 14 July 2025","DOI":"10.1021\/acs.jcim.4c02158"},{"key":"11504_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325","journal-title":"SoftwareX"},{"key":"11504_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/JCC.23354","author":"J Huang","year":"2013","unstructured":"Huang J, Mackerell AD (2013) CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J Comput Chem. https:\/\/doi.org\/10.1002\/JCC.23354","journal-title":"J Comput Chem"},{"key":"11504_CR29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.1c00645","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"11504_CR30","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:1100\u20131107","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"11504_CR31","first-page":"1","volume":"14","author":"W McKinney","year":"2011","unstructured":"McKinney W (2011) Pandas: a foundational Python library for data analysis and statistics. Python High Perform Sci Comput 14(9):1\u20139","journal-title":"Python High Perform Sci Comput"},{"issue":"5","key":"11504_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P (2007) Principles of QSAR models validation: internal and external. QSAR Comb Sci 26(5):694\u2013701. https:\/\/doi.org\/10.1002\/qsar.200610151","journal-title":"QSAR Comb Sci"},{"key":"11504_CR33","doi-asserted-by":"publisher","unstructured":"A new strategy of outlier detection for QSAR\/QSPR\u2014Cao (2010) J Comput Chem. Wiley Online Library. Accessed 22 July 2025. [Online]. Available: https:\/\/doi.org\/10.1002\/jcc.21351","DOI":"10.1002\/jcc.21351"},{"issue":"8","key":"11504_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jmgm.2008.01.002","volume":"26","author":"S Weaver","year":"2008","unstructured":"Weaver S, Gleeson MP (2008) The importance of the domain of applicability in QSAR modeling. J Mol Graph Model 26(8):1315\u20131326. https:\/\/doi.org\/10.1016\/j.jmgm.2008.01.002","journal-title":"J Mol Graph Model"},{"key":"11504_CR35","unstructured":"Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nat Commun. Accessed 22 July 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/ncomms7263"},{"issue":"D1","key":"11504_CR36","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/NAR\/GKY1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim S et al (2019) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47(D1):D1102\u2013D1109. https:\/\/doi.org\/10.1093\/NAR\/GKY1033","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"11504_CR37","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","volume":"12","author":"D Sun","year":"2022","unstructured":"Sun D, Gao W, Hu H, Zhou S (2022) Why 90% of clinical drug development fails and how to improve it? Acta Pharm Sin B 12(7):3049\u20133062. https:\/\/doi.org\/10.1016\/j.apsb.2022.02.002","journal-title":"Acta Pharm Sin B"},{"key":"11504_CR38","doi-asserted-by":"publisher","unstructured":"Modernizing preclinical drug development: the role of new approach methodologies. ACS Pharmacol Transl Sci. [Online]. Available: https:\/\/doi.org\/10.1021\/acsptsci.5c00162. Accessed 24 July 2025","DOI":"10.1021\/acsptsci.5c00162"},{"issue":"W1","key":"11504_CR39","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.1093\/nar\/gkae254","volume":"52","author":"Y Myung","year":"2024","unstructured":"Myung Y, de S\u00e1 AGC, Ascher DB (2024) Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res 52(W1):W1. https:\/\/doi.org\/10.1093\/nar\/gkae254","journal-title":"Nucleic Acids Res"},{"key":"11504_CR40","doi-asserted-by":"publisher","first-page":"6263","DOI":"10.1038\/ncomms7263","volume":"6","author":"T Rumpf","year":"2015","unstructured":"Rumpf T et al (2015) Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nat Commun 6:6263. https:\/\/doi.org\/10.1038\/ncomms7263","journal-title":"Nat Commun"},{"issue":"9","key":"11504_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ph16091316","volume":"16","author":"E Abbotto","year":"2023","unstructured":"Abbotto E et al (2023) Novel Thiazole-based SIRT2 inhibitors discovered via molecular modelling studies and enzymatic assays. Pharmaceuticals 16(9):9. https:\/\/doi.org\/10.3390\/ph16091316","journal-title":"Pharmaceuticals"},{"issue":"22","key":"11504_CR42","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.3390\/molecules28227655","volume":"28","author":"T Ai","year":"2023","unstructured":"Ai T, Wilson DJ, Chen L (2023) 5-((3-Amidobenzyl)oxy)nicotinamides as SIRT2 inhibitors: a study of constrained analogs. Molecules 28(22):7655. https:\/\/doi.org\/10.3390\/molecules28227655","journal-title":"Molecules"},{"issue":"3","key":"11504_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2000374","volume":"15","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira RM et al (2017) The mechanism of sirtuin 2\u2013mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 15(3):e2000374. https:\/\/doi.org\/10.1371\/journal.pbio.2000374","journal-title":"PLoS Biol"},{"issue":"5","key":"11504_CR44","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1021\/acs.jmedchem.6b01690","volume":"60","author":"S Sundriyal","year":"2017","unstructured":"Sundriyal S et al (2017) Thienopyrimidinone based sirtuin-2 (SIRT2)-selective inhibitors bind in the ligand induced selectivity pocket. J Med Chem 60(5):1928\u20131945. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01690","journal-title":"J Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11504-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11504-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11504-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:26:09Z","timestamp":1777904769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11504-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["11504"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11504-7","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}